Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as SkinJect Phase 2 Clinical Data Approaches Readout and Partnering Readiness Accelerates
-
MiniLuxe Announces Approval of Amendments to Equity Incentive Plan
-
Allot to Present at the Needham Growth Conference on January 14, 2026
-
Zenas BioPharma Announces Positive Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)
-
MEDIA ADVISORY: Sixth Anniversary Commemoration of the Downing of Flight PS752
-
Prospect Credit REIT Achieves 13.35% Annualized Total Return Versus 6.28% Stanger-Tracked Non-Traded REIT Average Through Q3 2025
-
Tango Therapeutics Appoints Sung Lee to Board of Directors
-
Alta Equipment Group Announces Preferred Stock Dividend
-
GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026
-
Lantronix Previews Turnkey Drone Reference Platform to Accelerate Defense and Commercial UAV Development
-
Beneficient Regains Full Compliance with Nasdaq Listing Requirements
-
Copper Quest Acquires 100% Interest in the Kitimat Copper-Gold Project
-
Nurix Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Stallion Uranium Announces Mobilization for Winter Drilling Program, Appoints Paulo Santos as Chief Financial Officer
-
Agios to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
-
iMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion
-
Dianthus Therapeutics To Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Evergold Announces $300,000 Ore Group Financing, Sharpened Focus on Golden Lion Project, Toodoggone District, Northern BC
-
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morg
-
Crescent Biopharma Announces Regulatory Clearances of IND Applications for CR-001, a PD-1 x VEGF Bispecific Antibody and CR-003, an ITGB6-targeted ADC, for the Treatment of Solid Tumors
-
Mobilicom Announces New Design Win and Initial Order from United Arab Emirates–Based Arms Manufacturer
-
OKYO Pharma Appoints Industry Veteran Robert J. Dempsey as Chief Executive Officer
-
Mobix Labs Powers Up U.S. Defense Operations: Veteran Defense GM Takes the Helm; Bigger Military-Approved Facility Expansion Planned
-
Beamr 2026 Strategy and 2025 Highlights
-
UMH PROPERTIES, INC. FOURTH QUARTER AND FULL YEAR 2025 OPERATIONS UPDATE
-
Gyre Therapeutics Announces Alignment with China’s CDE on Conditional Approval Pathway and Priority Review Eligibility for Hydronidone Following Pre-NDA Meeting
-
Enhance Your Dry January with Mindful Sipping: Try Tilray’s Mollo and XMG Cannabis Beverages
-
Cibus and Interoc Advance Rice Commercialization Strategy for Herbicide-Tolerant Traits in Key Markets across Latin America
-
MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer’s Disease Psychosis
-
Gogo issues year-end “report card” on critical new product initiatives.
-
Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer
-
Upstream Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Seyond to Showcase Live RoboVan Demonstrations and Next-Generation LiDAR at CES 2026
-
Orion Group Holdings Awarded $86.3 Million U.S. Army Corps of Engineers Project
-
ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026
-
Fractyl Health Enters a Catalyst-Rich 2026 Positioned to Define the Post-GLP-1 Weight Maintenance Therapeutic Category
-
OTC Markets Group Welcomes FPX Nickel Corp. to OTCQX
-
Frontier Medicines Announces Publication in Nature Communications Highlighting a Novel Method that Enables Next-Generation Covalent Medicines
-
Apellis Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Olema Oncology to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Maze Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Syndax Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference
-
Sonepar Kicks Off First-Ever National Customer Appreciation Month for Electrical Contractors
-
Transocean Ltd. Announces Contract Award and Extension Totaling $168 Million
-
NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions
-
YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
-
The emoji™ Brand Makes Its Web3 Gaming Debut with emoji™ Marble Dash
-
Scorpio Tankers Inc. Announces Time Charter-Out Agreements
-
Brookfield Business Partners to Host Fourth Quarter 2025 Results Conference Call
